{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T17:37:39Z","timestamp":1725817059114},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.drugalcdep.2006.01.009","type":"journal-article","created":{"date-parts":[[2006,2,15]],"date-time":"2006-02-15T12:21:06Z","timestamp":1140006066000},"page":"154-159","source":"Crossref","is-referenced-by-count":23,"title":["Factors associated with exposure to hepatitis B virus in injection drug users"],"prefix":"10.1016","volume":"84","author":[{"given":"Markus","family":"Backmund","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Schuetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Reimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2006.01.009_bib1","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1097\/00002030-200411190-00010","article-title":"Global overview of injecting drug use and HIV infection among injecting drug users","volume":"19","author":"Aceijas","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2006.01.009_bib2","first-page":"388","article-title":"Hepatitis B vaccination for injection drug users\u2014Pierce County, Washington, 2000","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"M.M.W.R. Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2006.01.009_bib3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF01719350","article-title":"HCV, HIV, HBV, and HDV infections in intravenous drug addicts","volume":"10","author":"Coppola","year":"1994","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2006.01.009_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1476-0711-4-13","article-title":"Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection","volume":"4","author":"Crocket","year":"2005","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"10.1016\/j.drugalcdep.2006.01.009_bib5","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1001\/archinte.162.18.2125","article-title":"Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects","volume":"162","author":"De Luca","year":"2002","journal-title":"Arch. Intern. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2006.01.009_bib6","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1002\/hep.1840360716","article-title":"Optimal therapy of hepatitis C","volume":"5","author":"Di Bisceglie","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2006.01.009_bib7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/01.qai.0000171727.55553.78","article-title":"Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: trends between 1996 and 2000 in 12 states","volume":"40","author":"Gebo","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2006.01.009_bib8","first-page":"1","article-title":"Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy","volume":"47","author":"Guadagnino","year":"1995","journal-title":"J. Clin. Lab. Immunol."},{"key":"10.1016\/j.drugalcdep.2006.01.009_bib9","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/00002030-199711000-00011","article-title":"The HIV epidemic associated with injecting drug use in Europe: geographic and time trends","volume":"11","author":"Hamers","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2006.01.009_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00002030-199509050-00012","article-title":"Changes in the injecting risk behaviour of injecting drug users in London, 1990\u20131993","volume":"9","author":"Hunter","year":"1995","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2006.01.009_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.drugalcdep.2003.10.007","article-title":"Hepatitis B virus infection and vaccination among young injection and non-injection drug users: missed opportunities to prevent infection","volume":"73","author":"Kuo","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2006.01.009_bib12","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0163-4453(98)92045-X","article-title":"Hepatitis B and hepatitis C virus infections: risk factors among drug users in Northwest England","volume":"37","author":"Lamden","year":"1998","journal-title":"J. Infect."},{"key":"10.1016\/j.drugalcdep.2006.01.009_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","article-title":"Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures","volume":"11","author":"Lavanchy","year":"2004","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.drugalcdep.2006.01.009_bib14","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1097\/00002030-200310170-00007","article-title":"Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996\u20132001","volume":"17","author":"Law","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2006.01.009_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/oxfordjournals.aje.a117639","article-title":"Seroepidemiology of hepatitis B virus in a population of injecting drug users: association with drug injection patterns","volume":"142","author":"Levine","year":"1995","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2006.01.009_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev.med.57.121304.131422","article-title":"Emerging therapeutics for chronic hepatitis B","volume":"57","author":"Mailliard","year":"2006","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.drugalcdep.2006.01.009_bib17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/00365540050165875","article-title":"Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe\/needle exchange program","volume":"32","author":"Mansson","year":"2000","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2006.01.009_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1017\/S0950268899002538","article-title":"Risk factors for monoinfections and coinfections with HIV, hepatitis B and hepatitis C viruses in northern Spanish prisoners","volume":"123","author":"Pallas","year":"1999","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.drugalcdep.2006.01.009_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.1440","article-title":"Estimating the world cancer burden: Globocean 2000","volume":"94","author":"Parkin","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.drugalcdep.2006.01.009_bib20","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2036.2004.01906.x","article-title":"Hepatitis vaccination in patients with chronic liver disease","volume":"19","author":"Reiss","year":"2004","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2006.01.009_bib21","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1017\/S0950268801006197","article-title":"Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA","volume":"127","author":"Samuel","year":"2001","journal-title":"Epidemiol. Infect."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2006.01.009_bib22","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1055\/s-2005-915646","article-title":"Management of HBV\/HIV-coinfection patients","volume":"25","author":"Shire","year":"2005","journal-title":"Semin. Liver Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.drugalcdep.2006.01.009_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-2004-832930","article-title":"Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection","volume":"24","author":"Sterling","year":"2004","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.drugalcdep.2006.01.009_bib24","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1537-2995.2002.00099.x","article-title":"Mathematic modelling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT","volume":"42","author":"Weusten","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.drugalcdep.2006.01.009_bib25","series-title":"Hepatitis C and Injecting Drug Use: Impact Costs and Policy Options.","article-title":"Surveillance of hepatitis C infection among injecting drug users in the European Union","author":"Wiessing","year":"2004"},{"key":"10.1016\/j.drugalcdep.2006.01.009_bib26","first-page":"30","article-title":"Seroepidemiology of viral infections among intravenous drug users in northern California","volume":"156","author":"Zeldis","year":"1992","journal-title":"West. J. Med."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871606000342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871606000342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T23:28:00Z","timestamp":1555457280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871606000342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0376871606000342"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2006.01.009","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}